10 C
London
Wednesday, November 18, 2026

Christina Applegate Investigates Breast Implants as Pain Source

Christina Applegate, 54, an actress, is currently investigating the possibility that her breast implants may be contributing to her pain and fatigue, following a misdiagnosis of multiple sclerosis (MS), which she was told she had in 2021.

During the Nov. 10 episode of the podcast MeSsy, which she co-hosts with Jamie-Lynn Sigler, Applegate, recognized for her role as a teenager in the popular sitcom Married With Children, mentioned that she received a study from someone that indicated symptoms related to breast implants are similar to those of MS.

“I can’t help but wonder, over the past five years or so, ‘What if they’re leaking and causing harm?'” she remarked, adding that she intends to speak with her doctors about this concern.

In 2008, Applegate underwent a double mastectomy and reconstruction after being diagnosed with an early stage of breast cancer and being found to have a BRCA1 gene mutation, which increases the likelihood of breast and other cancers. She mentioned on her podcast that she is “well overdue” for a replacement of her implants.

She has also shared that she is experiencing increased pain and has difficulty moving her right shoulder, often taking her at least 10 minutes to sit up and get out of bed. These symptoms, she explained, are distressing because “there are so many potential factors at play.”

Her inquiry follows an October assessment where doctors informed her that she does not have MS. At that time, Applegate expressed feeling as though she was back at “Square 1,” as her physical challenges persisted and she is now undergoing tests for other possible conditions, including rheumatoid arthritis, lupus, and Lyme disease.

Though the origin of Applegate’s symptoms remains unidentified, there are instances where breast implants have been connected to health issues, albeit the understanding of this condition is still limited.

Understanding Breast Implant Illness

As connections between breast implants and autoimmune diseases become clearer, women with breast implant illness urge doctors to warn others of the risks. Unknown hands hold a Biocell textured breast implant by Allergan.

Breast implant illness, or BII, refers to symptoms that some individuals with implants report, including fatigue, cognitive changes, joint pain, and muscle pain. The image depicts a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)

Breast implant illness, commonly referred to as BII, describes symptoms that some persons with implants experience.

As of December 31, 2025, Health Canada had logged 663 reports of symptoms or diseases linked to breast implants, which equates to roughly one report for every 1,025 implants sold in Canada.

Fatigue was the symptom reported most frequently, followed by mood changes, gastrointestinal issues, and cognitive shifts. It is important to note that these are reports rather than confirmed cases; Health Canada states that the existing data does not determine if implants were the cause of the symptoms, as other factors could be involved.

The U.S. Food and Drug Administration (FDA) states that BII is not an official medical diagnosis and lacks a specific test. Reports of symptoms such as fatigue and joint pain do not confirm how often they occur or if they are implant-related.

Julie Elliott, a Canadian advocate for breast implant illness and implant-related cancer, who claims to have faced health issues post-augmentation, told CBC News that certain symptoms reported by individuals with implants can overlap with those of MS.

“Chronic fatigue, memory changes, concentration issues, numbness, tingling, nerve pain, muscle weakness, and hair loss — these symptoms are akin to those of MS,” Elliott commented.

However, she cautioned against concluding that Applegate’s implants are the cause. “I’m not suggesting that Christina Applegate’s breast implants are the source of her issues,” she stated, stressing that it would be “premature and irresponsible” to assume they are the explanation.

“Just because symptoms are similar does not imply the same diagnosis,” Elliott advised. “No potential cause should be overlooked or dismissed without thorough medical investigation.”

A woman in a large black dress and carrying a black cane, poses on a red carpet.

Christina Applegate, left, arrives for the 29th Screen Actors Guild Awards in Century City, California, on Feb. 26, 2023. (Valerie Macon/AFP/Getty Images)

Dr. Stephen Nicolaidis, a plastic surgeon from Montreal who has treated over 1,500 patients for implant removal, also highlighted the importance of exploring other potential causes.

He characterized BII as a “diagnosis of exclusion,” asserting that patients must be thoroughly evaluated, and if no other causes are identified, the possibility that the implants may be causing issues should be considered.

Commonly reported symptoms include fatigue, hair loss, skin rashes, breathing difficulties, joint and muscle pain, sleep disturbances, and cognitive fog, many of which can overlap with autoimmune disease symptoms.

Referring to the symptoms Applegate has publicly mentioned, he noted, “Those symptoms she described could very well be linked to her breast implants.” However, the underlying cause of BII remains unclear, and he stated that definitive answers regarding the relationship between implants and symptoms are still pending.

There is no specific diagnostic test for BII, Nicolaidis added. While imaging might reveal silicone outside of an implant, such findings are not necessary for reporting symptoms. He also emphasized that BII is distinct from implant-associated lymphoma, a type of cancer connected to certain textured implants.

Rupture, Removal, and Future Steps

A rupture or leak presents a different concern compared to BII. The FDA lists rupture and deflation among the possible complications associated with implants and recommends that patients consult a healthcare provider regarding any new or unusual changes in their breasts.

Likewise, Health Canada advises individuals with implants to regularly monitor for unusual breast changes and to discuss any signs or symptoms with their physician. Decisions regarding the retention, replacement, or removal of implants should be made in consultation with a clinician, taking into account personal symptoms, potential causes, and surgical risks, according to the agency.

Preventive removal of implants is not recommended due to the associated surgical risks, and individuals experiencing symptoms should address them with a healthcare professional.

Nicolaidis recommended that individuals experiencing symptoms pursue a comprehensive medical assessment. If other causes are ruled out, they can discuss the potential impact of implants and consider options with their healthcare providers.

He ceased performing breast implant procedures in 2021 due to the belief that the associated risks often outweigh the benefits, and now primarily focuses on implant removals. He noted that removal does not guarantee relief; some patients who have been treated for MS have reported only minimal improvement, and those with diagnosed autoimmune disorders may still require medical care after undergoing explant surgery.

Elliott asserted that symptoms related to implants warrant serious consideration, even while acknowledging that their origins remain unclear. She urged patients to seek well-rounded, evidence-based information and to monitor their health developments closely.

“The absence of complete answers does not justify dismissing women’s experiences,” she concluded.

Source

Latest news
Related news